{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:21:53Z","timestamp":1792167713827,"version":"4.4.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Acute myeloid leukemia (AML) patients older than 65\u00a0years have a poor prognosis. Recently, CAR (C-reactive-protein\/albumin ratio) has been actively reported as a prognostic index reflecting the nutritional and inflammatory status of elderly patients with solid tumors, but the usefulness of this index as a prognostic indicator in transplant-ineligible elderly AML patients has not been investigated. We studied genetic alterations and CARs in 188 newly diagnosed AML patients aged 65\u00a0years or older who were treated in a multicenter setting and had treated without HSCT. Both NCCN 2017 risk group, reflecting the genetic component of the tumor, and CAR, reflecting the inflammatory and nutritional status of the patient, successfully stratified the overall survival (OS) of the patients (2-year OS; CAR low vs high, 42.3% vs 17.8%, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Furthermore, in multivariate analysis, NCCN 2017 poor group and high CAR were extracted as independent poor prognostic factors predicting 2-year OS in the current study. We found, for the first time, that CAR at diagnosis predicted the prognosis of elderly patients with newly diagnosed AML treated without HSCT.<\/jats:p>","DOI":"10.1038\/s41598-022-12813-1","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T16:03:33Z","timestamp":1653494613000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["High CRP-albumin ratio predicts poor prognosis in transplant ineligible elderly patients with newly diagnosed acute myeloid leukemia"],"prefix":"10.1038","volume":"12","author":[{"given":"Hajime","family":"Senjo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Onozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Hidaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Tsutsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihito","family":"Haseyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Nagashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshimichi","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuto","family":"Miyagishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutaka","family":"Kakinoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsutoshi","family":"Kurosawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daigo","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Teshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,25]]},"reference":[{"key":"12813_CR1","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/cncr.33873","volume":"128","author":"VE Kennedy","year":"2022","unstructured":"Kennedy, V. E., Keegan, T. H. M., Li, Q., Maguire, F. B. & Muffly, L. S. Frontline treatment patterns and outcomes among older adults with acute myeloid leukemia: A population-based analysis in the modern era. Cancer 128, 139\u2013149 (2022).","journal-title":"Cancer"},{"key":"12813_CR2","doi-asserted-by":"publisher","first-page":"926","DOI":"10.6004\/jnccn.2017.0116","volume":"15","author":"MR O\u2019Donnell","year":"2017","unstructured":"O\u2019Donnell, M. R. et al. Acute myeloid leukemia, Version 3.2017, NCCN clinical practice guidelines in oncology. J. Natl. Compr. Cancer Netw. 15, 926\u2013957 (2017).","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"12813_CR3","doi-asserted-by":"publisher","first-page":"19400","DOI":"10.1038\/s41598-020-76250-8","volume":"10","author":"H Senjo","year":"2020","unstructured":"Senjo, H. et al. A novel nutritional index \u201csimplified CONUT\u201d and the disease risk index independently stratify prognosis of elderly patients with acute myeloid leukemia. Sci. Rep. 10, 19400 (2020).","journal-title":"Sci. Rep."},{"key":"12813_CR4","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1186\/s12885-015-1379-6","volume":"15","author":"X Wei","year":"2015","unstructured":"Wei, X. et al. A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: The C-reactive protein\/albumin ratio. BMC Cancer 15, 350 (2015).","journal-title":"BMC Cancer"},{"key":"12813_CR5","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.tranon.2015.06.006","volume":"8","author":"X Liu","year":"2015","unstructured":"Liu, X. et al. Preoperative C-reactive protein\/albumin ratio predicts prognosis of patients after curative resection for gastric cancer. Transl. Oncol. 8, 339\u2013345 (2015).","journal-title":"Transl. Oncol."},{"key":"12813_CR6","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1245\/s10434-014-4048-0","volume":"22","author":"A Kinoshita","year":"2015","unstructured":"Kinoshita, A. et al. The C-reactive protein\/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma. Ann. Surg. Oncol. 22, 803\u2013810 (2015).","journal-title":"Ann. Surg. Oncol."},{"key":"12813_CR7","doi-asserted-by":"publisher","first-page":"29351","DOI":"10.18632\/oncotarget.25486","volume":"9","author":"T Toyokawa","year":"2018","unstructured":"Toyokawa, T. et al. Comparison of the prognostic impact and combination of preoperative inflammation-based and\/or nutritional markers in patients with stage II gastric cancer. Oncotarget 9, 29351\u201329364 (2018).","journal-title":"Oncotarget"},{"key":"12813_CR8","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.bbmt.2019.01.006","volume":"25","author":"E Miyashita","year":"2019","unstructured":"Miyashita, E. et al. The prognostic impact of pretransplantation inflammatory and nutritional status in adult patients after myeloablative single cord blood transplantation. Biol. Blood Marrow Transplant. 25, 981\u2013988 (2019).","journal-title":"Biol. Blood Marrow Transplant."},{"key":"12813_CR9","doi-asserted-by":"publisher","first-page":"e469","DOI":"10.1016\/j.clml.2018.07.291","volume":"18","author":"D Hidaka","year":"2018","unstructured":"Hidaka, D. et al. Wilms tumor 1 expression at diagnosis correlates with genetic abnormalities and polymorphism but is not independently prognostic in acute myelogenous leukemia: A hokkaido leukemia net study. Clin. Lymphoma Myeloma Leuk. 18, e469\u2013e479 (2018).","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"12813_CR10","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda, Y. Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transplant. 48, 452\u2013458 (2013).","journal-title":"Bone Marrow Transplant."},{"key":"12813_CR11","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1056\/NEJMra1406184","volume":"373","author":"H D\u00f6hner","year":"2015","unstructured":"D\u00f6hner, H., Weisdorf, D. J. & Bloomfield, C. D. Acute myeloid leukemia. N. Engl. J. Med. 373, 1136\u20131152 (2015).","journal-title":"N. Engl. J. Med."},{"key":"12813_CR12","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1182\/blood-2010-07-295279","volume":"117","author":"S Miyawaki","year":"2011","unstructured":"Miyawaki, S. et al. A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: The JALSG AML201 Study. Blood 117, 2366\u20132372 (2011).","journal-title":"Blood"},{"key":"12813_CR13","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1182\/blood-2010-03-273243","volume":"117","author":"S Ohtake","year":"2011","unstructured":"Ohtake, S. et al. Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: The JALSG AML201 study. Blood 117, 2358\u20132365 (2011).","journal-title":"Blood"},{"key":"12813_CR14","doi-asserted-by":"publisher","first-page":"4422","DOI":"10.1182\/blood-2010-03-276485","volume":"116","author":"H Kantarjian","year":"2010","unstructured":"Kantarjian, H. et al. Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia. Blood 116, 4422\u20134429 (2010).","journal-title":"Blood"},{"key":"12813_CR15","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.jgo.2015.04.002","volume":"6","author":"SMH Alibhai","year":"2015","unstructured":"Alibhai, S. M. H. et al. Quality of life and physical function in adults treated with intensive chemotherapy for acute myeloid leukemia improve over time independent of age. J. Geriatr. Oncol. 6, 262\u2013271 (2015).","journal-title":"J. Geriatr. Oncol."},{"key":"12813_CR16","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s00277-021-04482-3","volume":"100","author":"O Ballo","year":"2021","unstructured":"Ballo, O. et al. Acute kidney injury poorly affects the clinical course of acute myeloid leukemia patients undergoing induction chemotherapy. Ann. Hematol. 100, 1159\u20131167 (2021).","journal-title":"Ann. Hematol."},{"key":"12813_CR17","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.bbmt.2008.08.004","volume":"14","author":"AS Artz","year":"2008","unstructured":"Artz, A. S. et al. Pretreatment C-reactive protein is a predictor for outcomes after reduced-intensity allogeneic hematopoietic cell transplantation. Biol. Blood Marrow Transplant. 14, 1209\u20131216 (2008).","journal-title":"Biol. Blood Marrow Transplant."},{"key":"12813_CR18","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/bmt.2010.108","volume":"46","author":"J Kanda","year":"2011","unstructured":"Kanda, J. et al. Pretransplant serum ferritin and C-reactive protein as predictive factors for early bacterial infection after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 46, 208\u2013216 (2011).","journal-title":"Bone Marrow Transplant."},{"key":"12813_CR19","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/bmt.2012.193","volume":"48","author":"M Sato","year":"2013","unstructured":"Sato, M. et al. Prediction of transplant-related complications by C-reactive protein levels before hematopoietic SCT. Bone Marrow Transplant. 48, 698\u2013702 (2013).","journal-title":"Bone Marrow Transplant."},{"key":"12813_CR20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nrc1256","volume":"4","author":"JW Pollard","year":"2004","unstructured":"Pollard, J. W. Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer 4, 71\u201378 (2004).","journal-title":"Nat. Rev. Cancer"},{"key":"12813_CR21","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.3390\/cancers6031500","volume":"6","author":"R Wisastra","year":"2014","unstructured":"Wisastra, R. & Dekker, F. J. Inflammation, cancer and oxidative lipoxygenase activity are intimately linked. Cancers 6, 1500\u20131521 (2014).","journal-title":"Cancers"},{"key":"12813_CR22","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/S0140-6736(89)92042-4","volume":"2","author":"A Phillips","year":"1989","unstructured":"Phillips, A., Shaper, A. G. & Whincup, P. H. Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes. Lancet 2, 1434\u20131436 (1989).","journal-title":"Lancet"},{"key":"12813_CR23","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/0002-8703(92)90667-K","volume":"123","author":"RF Gillum","year":"1992","unstructured":"Gillum, R. F. & Makuc, D. M. Serum albumin, coronary heart disease, and death. Am. Heart J. 123, 507\u2013513 (1992).","journal-title":"Am. Heart J."},{"key":"12813_CR24","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1001\/jama.1994.03520130074036","volume":"272","author":"MC Corti","year":"1994","unstructured":"Corti, M. C., Guralnik, J. M., Salive, M. E. & Sorkin, J. D. Serum albumin level and physical disability as predictors of mortality in older persons. JAMA 272, 1036\u20131042 (1994).","journal-title":"JAMA"},{"key":"12813_CR25","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/0895-4356(96)00135-7","volume":"49","author":"NR Sahyoun","year":"1996","unstructured":"Sahyoun, N. R., Jacques, P. F., Dallal, G. & Russell, R. M. Use of albumin as a predictor of mortality in community dwelling and institutionalized elderly populations. J. Clin. Epidemiol. 49, 981\u2013988 (1996).","journal-title":"J. Clin. Epidemiol."},{"key":"12813_CR26","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/S0895-4356(97)00015-2","volume":"50","author":"P Goldwasser","year":"1997","unstructured":"Goldwasser, P. & Feldman, J. Association of serum albumin and mortality risk. J. Clin. Epidemiol. 50, 693\u2013703 (1997).","journal-title":"J. Clin. Epidemiol."},{"key":"12813_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3177\/jnsv.53.37","volume":"53","author":"I Gom","year":"2007","unstructured":"Gom, I. et al. Relationship between serum albumin level and aging in community-dwelling self-supported elderly population. J. Nutr. Sci. Vitaminol. 53, 37\u201342 (2007).","journal-title":"J. Nutr. Sci. Vitaminol."},{"key":"12813_CR28","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.18632\/aging.102642","volume":"12","author":"K-Y Lai","year":"2020","unstructured":"Lai, K.-Y. et al. Body mass index and albumin levels are prognostic factors for long-term survival in elders with limited performance status. Aging 12, 1104\u20131113 (2020).","journal-title":"Aging"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12813-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12813-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12813-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T03:55:48Z","timestamp":1669348548000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-12813-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,25]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["12813"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-12813-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,25]]},"assertion":[{"value":"25 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8885"}}